Transgender Identity and Suicide Attempts and Mortality in Denmark.


Journal

JAMA
ISSN: 1538-3598
Titre abrégé: JAMA
Pays: United States
ID NLM: 7501160

Informations de publication

Date de publication:
27 06 2023
Historique:
pmc-release: 27 12 2023
medline: 29 6 2023
pubmed: 27 6 2023
entrez: 27 6 2023
Statut: ppublish

Résumé

Prior studies have suggested that transgender individuals may be a high-risk group with respect to suicide attempt and mortality, but large-scale, population-based investigations are lacking. To examine in a national setting whether transgender individuals have higher rates of suicide attempt and mortality than nontransgender individuals. Nationwide, register-based, retrospective cohort study on all 6 657 456 Danish-born individuals aged 15 years or older who lived in Denmark between January 1, 1980, and December 31, 2021. Transgender identity was determined through national hospital records and administrative records of legal change of gender. Suicide attempts, suicide deaths, nonsuicidal deaths, and deaths by any cause during 1980 through 2021 were identified in national hospitalization and causes of death registers. Adjusted incidence rate ratios (aIRRs) with 95% CIs controlling for calendar period, sex assigned at birth, and age were calculated. The 6 657 456 study participants (50.0% assigned male sex at birth) were followed up during 171 023 873 person-years. Overall, 3759 individuals (0.06%; 52.5% assigned male sex at birth) were identified as transgender at a median age of 22 years (IQR, 18-31 years) and followed up during 21 404 person-years, during which 92 suicide attempts, 12 suicides, and 245 suicide-unrelated deaths occurred. Standardized suicide attempt rates per 100 000 person-years were 498 for transgender vs 71 for nontransgender individuals (aIRR, 7.7; 95% CI, 5.9-10.2). Standardized suicide mortality rates per 100 000 person-years were 75 for transgender vs 21 for nontransgender individuals (aIRR, 3.5; 95% CI, 2.0-6.3). Standardized suicide-unrelated mortality rates per 100 000 person-years were 2380 for transgender vs 1310 for nontransgender individuals (aIRR, 1.9; 95% CI, 1.6-2.2), and standardized all-cause mortality rates per 100 000 person-years were 2559 for transgender vs 1331 for nontransgender individuals (aIRR, 2.0; 95% CI, 1.7-2.4). Despite declining rates of suicide attempts and mortality during the 42 years covered, aIRRs remained significantly elevated in recent calendar periods up to and including 2021 for suicide attempts (aIRR, 6.6; 95% CI, 4.5-9.5), suicide mortality (aIRR, 2.8; 95% CI, 1.3-5.9), suicide-unrelated mortality (aIRR, 1.7; 95% CI, 1.5-2.1), and all-cause mortality (aIRR, 1.7; 95% CI, 1.4-2.1). In this Danish population-based, retrospective cohort study, results suggest that transgender individuals had significantly higher rates of suicide attempt, suicide mortality, suicide-unrelated mortality, and all-cause mortality compared with the nontransgender population.

Identifiants

pubmed: 37367977
pii: 2806531
doi: 10.1001/jama.2023.8627
pmc: PMC10300682
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2145-2153

Références

Eur J Endocrinol. 2011 Apr;164(4):635-42
pubmed: 21266549
Crisis. 2016 Jul;37(4):256-264
pubmed: 27278571
Eur Psychiatry. 2015 Sep;30(6):807-15
pubmed: 26021270
LGBT Health. 2021 Apr;8(3):173-180
pubmed: 33544021
Soc Sci Med. 2015 Dec;147:222-31
pubmed: 26599625
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
PLoS One. 2011 Feb 22;6(2):e16885
pubmed: 21364939
J Homosex. 2016 Oct;63(10):1378-99
pubmed: 26914181
Transgend Health. 2017 Feb 01;2(1):17-28
pubmed: 28861545
Scand J Public Health. 2011 Jul;39(7 Suppl):54-7
pubmed: 21775352
Scand J Public Health. 2011 Jul;39(7 Suppl):22-5
pubmed: 21775345
Scand J Public Health. 2011 Jul;39(7 Suppl):30-3
pubmed: 21775347
JAMA Netw Open. 2023 Jan 3;6(1):e2253687
pubmed: 36716027
Demography. 2022 Jun 1;59(3):1023-1043
pubmed: 35548863
Scand J Public Health. 2011 Jul;39(7 Suppl):26-9
pubmed: 21775346
Perspect Psychol Sci. 2019 May;14(3):452-468
pubmed: 30946622
J Homosex. 2011;58(1):10-51
pubmed: 21213174
Psychol Bull. 2003 Sep;129(5):674-697
pubmed: 12956539
J Sex Med. 2016 Apr;13(4):613-26
pubmed: 27045261
BMJ Open. 2015 Nov 25;5(11):e009120
pubmed: 26608638
Scand J Public Health. 2015 Jun;43(4):333-9
pubmed: 25759376
Lancet Diabetes Endocrinol. 2021 Oct;9(10):663-670
pubmed: 34481559
Arch Suicide Res. 2023 Apr-Jun;27(2):415-425
pubmed: 34877921
Acta Psychiatr Scand. 2020 Jun;141(6):486-491
pubmed: 32072611
J Am Med Assoc. 1953 May 30;152(5):391-6
pubmed: 13044539
Behav Med. 2015;41(3):164-71
pubmed: 26287284

Auteurs

Annette Erlangsen (A)

Danish Research Institute for Suicide Prevention, Mental Health Centre Copenhagen, Copenhagen, Denmark.
Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Center of Mental Health Research, Australian National University, Canberra, Australia.
Copenhagen Research Center for Mental Health, Mental Health Centre Copenhagen, Copenhagen, Denmark.

Anna Lund Jacobsen (AL)

Danish Research Institute for Suicide Prevention, Mental Health Centre Copenhagen, Copenhagen, Denmark.

Anne Ranning (A)

Danish Research Institute for Suicide Prevention, Mental Health Centre Copenhagen, Copenhagen, Denmark.
Copenhagen Research Center for Mental Health, Mental Health Centre Copenhagen, Copenhagen, Denmark.
Department of Psychology, University of Copenhagen, Copenhagen, Denmark.

Alex Lauridsen Delamare (AL)

Counselling Services, LBGT+ Denmark, Copenhagen, Denmark.

Merete Nordentoft (M)

Danish Research Institute for Suicide Prevention, Mental Health Centre Copenhagen, Copenhagen, Denmark.
Copenhagen Research Center for Mental Health, Mental Health Centre Copenhagen, Copenhagen, Denmark.
Institute of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.

Morten Frisch (M)

Department of Epidemiology Research, Project SEXUS Group, Statens Serum Institut, Copenhagen, Denmark.
Center for Sexology Research, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH